Sujal M. Patel - 30 Nov 2021 Form 4 Insider Report for Nautilus Biotechnology, Inc. (NAUT)

Role
CEO, President, and Secretary, Director, 10%+ Owner
Signature
/s/ Matthew B. Murphy, as Attorney-in-Fact
Issuer symbol
NAUT
Transactions as of
30 Nov 2021
Net transactions value
+$1,181,176
Form type
4
Filing time
02 Dec 2021, 07:49:57 UTC
Previous filing
09 Jun 2021
Next filing
25 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NAUT Common Stock Purchase $764,779 +161,978 +1.7% $4.72 9,776,366 30 Nov 2021 Direct F1
transaction NAUT Common Stock Purchase $416,397 +88,022 +0.9% $4.73 9,864,388 01 Dec 2021 Direct F2
holding NAUT Common Stock 5,280,476 30 Nov 2021 By PFV I, LLC F3
holding NAUT Common Stock 1,814,035 30 Nov 2021 By Sujal Patel 2020 Children's Trust, u/a/d December 3, 2020 F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the weighted average share price of an aggregate total of 161,978 shares purchased in the price range of $4.48 to $4.85 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
F2 Represents the weighted average share price of an aggregate total of 88,022 shares purchased in the price range of $4.44 to $5.00 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
F3 Shares held by PFV I, LLC. The reporting person is the manager of PFV I, LLC.
F4 Shares held by Sujal Patel 2020 Children's Trust, u/a/d December 3, 2020 (the "Patel Trust"). The reporting person and the reporting person's spouse are the trustees of the Patel Trust.